In This Article:
-
Shares of McDermott International, Inc. MDR gained 27.2% after the engineering and construction services provider to the energy industry said that it was exploring the sale of its Lummus Technology business.
-
Shares of Merck & Co., Inc. MRK rose 1.4% after the FDA approved the company’s drugs Pifeltro and Delstrigo for “virally suppressed” HIV-1 patients.
-
Shares of Netflix, Inc. NFLX declined 5.5% after CEO Reed Hastings warned of tough competition from Apple and Disney.
-
Shares of Xilinx, Inc. XLNX dropped 6.8% after the chipmaker’s CFO Lorenzo Flores said he was stepping down.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Netflix, Inc. (NFLX) : Free Stock Analysis Report
Merck & Co., Inc. (MRK) : Free Stock Analysis Report
McDermott International, Inc. (MDR) : Free Stock Analysis Report
Xilinx, Inc. (XLNX) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research